NYC TRAC Spotlight - Dr. Jonah Kreniske
April 7, 2025
(Dr. Kreniske: 2nd from the right in the back row)
This month, we are pleased to feature Dr. Jonah Kreniske, Instructor in Medicine at Weill Cornell Medicine, whose research focuses on the long-term health consequences of TB in people with and without HIV. He is one of the recent awardees of our Developmental Project Award.
Dr. Kayvan Zainabadi Initiates Project to Evaluate a New Molecular Diagnostic for Tuberculosis (TB)
February 3, 2025
Dr. Kayvan Zainabadi, a TRAC awardee from our first cohort, is initiating a project supported by RePORT (Regional Prospective Observational Research in Tuberculosis) International/NIAID and administered though CRDF. Dr. Zainabadi is the principle investigator and is joined by another Center Associate P
The Union Conference 2024
January 3, 2025
Photo 1: (From left to right) Dr. Kathryn Dupnik, Dr. Kathleen Walsh, Dr. Jyoti Mathad, Dr. Melanie Dubois, Dr. Andrea Doltrario
In November 2024, two of our TRAC grant recipients – Dr. Kathleen Walsh and Dr. Andrea Doltrario, two investigators supported by NYC TRAC – Dr. Melanie Dubois and Dr. Kathryn Dupnik, and a Clinical Science Expert in NYC TRAC – Dr. Jyoti Mathad, joined and gave presentations at the Union World Conference on Lung Health 2024, which occurred in Bali, Indonesia. The details of oral research presentations by Dr. Walsh and Dr. Doltrario are below.
2nd Annual Symposium of NYC Tri-I TRAC
November 26, 2024
On November 25, we successfully organized the 2nd annual NYC Tri-I TRAC symposium at Weill Cornell Medicine in New York. This year’s event featured a diverse lineup of presentations, including proposals from current seed-grant recipients, updates from past investigators supported by NYC TRAC, and a guest speaker from SEATRAC, another TRAC based in Seattle.
The first session was dedicated to presentations by the current seed-grant recipients. Below is the list of speakers and their presentation titles:
NIAID TRACs Annual Meeting at UC Berkeley
October 25, 2024
Two early stage investigators from our NYC TRAC, Dr. Christopher Brown and Dr. Kohta Saito, shared their recent findings at the NIH conference.
The Tri-Institute TB Research Unit (TBRU) Annual Meeting
June 10, 2024
The Tri-Institutional Tuberculosis Research Unit (Tri-I TBRU) successfully hosted its annual meeting on June 5, 2024, at Rockefeller Research Labs. The Tri-I TBRU is a collaboration between Weill Cornell, Rockefeller University, and Memorial Sloan Kettering Cancer Center which focuses on improving understanding of the persistence of Mycobacterium tuberculosis (Mtb) in humans during drug treatment and latency.
'The TB Treatment Landscape: 2024' – by Dr. Susan Dorman
May 2, 2024
On April 30, The NYC-TRAC hosted Dr. Susan Dorman, Professor of Medicine at the Medical University of South Carolina in Charleston, who has co-authored national guidelines for management of TB and leads a research team that focuses on development of new TB diagnostics and treatments. Dr. Dorman gave a talk entitled "The TB Treatment Landscape: 2024," which provided a comprehensive update on TB research and its promising future.
The Black Angels - The Untold Story of The Nurses Who Helped Cure Tuberculosis
April 1, 2024
On April 1, we had the pleasure of hosting Maria Smilios, author of the book titled "The Black Angels: The Untold Story of The Nurses Who Helped Cure Tuberculosis." This book sheds light on the contributions of Black nurses at Sea View Hospital in Staten Island, New York, from the early 1900s through World War II until the 1960s. Despite facing discrimination, these nurses provided compassionate care to thousands of people with tuberculosis (TB) over decades and participated in drug trials that ultimately led to the successful treatment and cure of the disease.
New Publication - Drug-Resistant Tuberculosis Responds Rapidly to Bedaquiline-based Second-Line Therapy
March 19, 2024
The study, published Dec. 7 in The Journal of Infectious Disease, “is thought to be the first to address the knowledge gap surrounding the microbiological response of patients receiving these two therapies,” said the paper’s lead author Dr. Kayvan Zainabadi, assistant professor of molecular microbiology at Weill Cornell Medicine.
TBRU Myco3V Scientific Advisory Board in South Africa
March 1, 2024
Report by Dr. Andrea Doltrario, a Postdoctoral Associate in Medicine at Weill Cornell Medicine about participation in the Tuberculosis Research Units (TBRU) Myco3V Scientific Advisory Board (SAB) meeting